1672-2809
2014 Issue 7
..............page:6-7
The benefits and risks of hormonereplacement therapy for perimenopausal syndrome
li ping ;, ni zuo ;, shi ying li ;
li ping ;, ni zuo ;, shi ying li ;
..............page:8-10,14
ClUinical Status of DPP-4 Inhibitors inpdating Guidelines
liu chao ;, xu shu hang ;
liu chao ;, xu shu hang ;
..............page:11-14
Relationship between structure and efficiency of different dipeptidyl peptidase-4 inhibitors and their pharmacokinetic characteristics
chen xin ;, di suo di ;
chen xin ;, di suo di ;
..............page:15-20
T he unique mechanism of Dipeptidylpeptidase-4 inhibitors：regulating effects on bothα-islet cells andβ-islet cells
li yi ming ;
li yi ming ;
..............page:21-25
Dipeptidyl peptidase-4 inhibitors:morethan an anti-hyperglycemia agent
li zuo ;, liu xiao dan ;
li zuo ;, liu xiao dan ;
..............page:26-28,35
S olid evidences of dipeptidyl peptidase-4inhibitors’ efficacy:the research data in Chinese patients
zhu da long ;
zhu da long ;
..............page:29-35
Efficacy and Safety of Dipeptidylpeptidase-4 inhibitors
sun zi lin ;, yang zuo xiao xiao ;
sun zi lin ;, yang zuo xiao xiao ;
..............page:36-43
Reduce the risk of hypoglycemia indiabetes treatment
ji qiu he ;, liu xiang yang ;
ji qiu he ;, liu xiang yang ;
..............page:44-48